000304101 001__ 304101
000304101 005__ 20250828140036.0
000304101 0247_ $$2doi$$a10.3892/ol.2025.15229
000304101 0247_ $$2ISSN$$a1792-1074
000304101 0247_ $$2ISSN$$a1792-1082
000304101 037__ $$aDKFZ-2025-01769
000304101 082__ $$a610
000304101 1001_ $$aRodriguez, Isaac$$b0
000304101 245__ $$aRadiomics-based prediction of HCC response to atezolizumab/bevacizumab
000304101 260__ $$aAthens$$bSpandidos Publ.$$c2025
000304101 3367_ $$2DRIVER$$aarticle
000304101 3367_ $$2DataCite$$aOutput Types/Journal article
000304101 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1756382409_18470
000304101 3367_ $$2BibTeX$$aARTICLE
000304101 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000304101 3367_ $$00$$2EndNote$$aJournal Article
000304101 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000304101 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000304101 7001_ $$aVellala, Abhinay$$b1
000304101 7001_ $$aItzel, Timo$$b2
000304101 7001_ $$aDaza, Jimmy$$b3
000304101 7001_ $$aVácha, Michael$$b4
000304101 7001_ $$aChang, De-Hua$$b5
000304101 7001_ $$aDebic, Manuel$$b6
000304101 7001_ $$0P:(DE-He78)54a6641a6c26ddc49cc754740e90b438$$aDill, Michael$$b7$$udkfz
000304101 7001_ $$aSeidensticker, Max$$b8
000304101 7001_ $$aMayerle, Julia$$b9
000304101 7001_ $$aMunker, Stefan$$b10
000304101 7001_ $$aSchoenberg, Stefan$$b11
000304101 7001_ $$aMüller, Lukas$$b12
000304101 7001_ $$aGalle, Peter$$b13
000304101 7001_ $$aWeinmann, Arndt$$b14
000304101 7001_ $$aTamandl, Dietmar$$b15
000304101 7001_ $$aPinter, Matthias$$b16
000304101 7001_ $$aScheiner, Bernhard$$b17
000304101 7001_ $$aWeiss, Christel$$b18
000304101 7001_ $$aPech, Maciej$$b19
000304101 7001_ $$aSinner, Friedrich$$b20
000304101 7001_ $$aKeitel, Verena$$b21
000304101 7001_ $$aVenerito, Marino$$b22
000304101 7001_ $$aEbert, Matthias$$b23
000304101 7001_ $$aTeufel, Andreas$$b24
000304101 7001_ $$aFroelich, Matthias$$b25
000304101 773__ $$0PERI:(DE-600)2573196-8$$a10.3892/ol.2025.15229$$gVol. 30, no. 4, p. 1 - 12$$n4$$p484$$tOncology letters$$v30$$x1792-1074$$y2025
000304101 909CO $$ooai:inrepo02.dkfz.de:304101$$pVDB
000304101 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)54a6641a6c26ddc49cc754740e90b438$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000304101 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000304101 9141_ $$y2025
000304101 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONCOL LETT : 2022$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
000304101 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
000304101 9201_ $$0I:(DE-He78)D500-20160331$$kD500$$lNWG Experimentelle Hepatologie, Entzündung und Krebs$$x0
000304101 980__ $$ajournal
000304101 980__ $$aVDB
000304101 980__ $$aI:(DE-He78)D500-20160331
000304101 980__ $$aUNRESTRICTED